ProfileGDS5822 / ILMN_1244631
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 88% 81% 78% 88% 82% 86% 88% 86% 85% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1351.488
GSM1276600PDAC Late Ablation Control 216381
GSM1276601PDAC Late Ablation Control 3160.578
GSM1276602PDAC Late Ablation 1384.788
GSM1276603PDAC Late Ablation 2180.582
GSM1276604PDAC Late Ablation 331786
GSM1303940PDAC Late Ablation_anti-CTLA4 1374.688
GSM1303941PDAC Late Ablation_anti-CTLA4 2372.786
GSM1303942PDAC Late Ablation_anti-CTLA4 3325.885